GlaxoSmithKline occused of hiding information on suicide risk of Paxil

Analysis of recently released internal GlaxoSmithKline memos and reports is suggesting that GSK had obscured data indicating that Paxil (paroxetine), a popular and profitable antidepressant medication, produces an eightfold increase in suicide risk. GSK is accused of having engaged in obviously illegitimate scientific practices in the analysis and presentation of data so as to not display … Continue reading